Vincerx Pharma, Inc. Warrant
VINCW
VINCW was delisted on the 5th of May, 2021.
17 hedge funds and large institutions have $20.2M invested in Vincerx Pharma, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
49% more capital invested
Capital invested by funds: $13.6M → $20.2M (+$6.62M)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
6% less funds holding
Funds holding: 18 → 17 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.77M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.11M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.02M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.72M |
| 5 |
AC
Athanor Capital
New York
|
+$316K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$693K |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$660K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$536K |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$214K |
| 5 |
HF
HRT Financial
New York
|
-$127K |
VINCW Hedge Fund Activity: Q1 2021 in Review
17 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Warrant (VINCW) for Q1 2021, worth a combined $20.2M — up 49% from $13.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VINCW and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Tang Capital Management, adding an estimated $2.77M. The largest seller was Sio Capital Management, exiting entirely with an estimated $693K sold.
- 17 institutional investors held Vincerx Pharma, Inc. Warrant (VINCW) as of Q1 2021, down from 18 in Q4 2020.
- Funds reported $20.2M of Vincerx Pharma, Inc. Warrant stock for Q1 2021, up 49% quarter-over-quarter.
- 4 funds opened new Vincerx Pharma, Inc. Warrant positions in Q1 2021 and 5 closed out, a net change of -1 holder.
- The largest Vincerx Pharma, Inc. Warrant buyer in Q1 2021 was Tang Capital Management, an estimated $2.77M added.
- The largest Vincerx Pharma, Inc. Warrant seller in Q1 2021 was Sio Capital Management, an estimated $693K sold.
Based on aggregated 13F filings for Q1 2021.